University of Bristol and Celltech R&D Limited
Lead Participant:
UNIVERSITY OF BRISTOL
Abstract
To develop a multicellular model of human Glomerulosclerosis into a medium throughput, highly quality controlled platform for drug screening of anti fibrotic molecules and stratifying patients for suitability into clinical trials. This will transform UCB's drug development process.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| UNIVERSITY OF BRISTOL | £149,907 | £ 74,954 |
Participant |
||
| CELLTECH R&D LIMITED | ||
| KTN LTD |
People |
ORCID iD |